These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26435485)

  • 41. The utilization of sodium taurocholate in excystation of Cryptosporidium parvum and infection of tissue culture.
    Gold D; Stein B; Tzipori S
    J Parasitol; 2001 Oct; 87(5):997-1000. PubMed ID: 11695421
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of Calcium-Dependent Protein Kinase 1 (CDPK1) In Vitro by Pyrazolopyrimidine Derivatives Does Not Correlate with Sensitivity of Cryptosporidium parvum Growth in Cell Culture.
    Kuhlenschmidt TB; Rutaganira FU; Long S; Tang K; Shokat KM; Kuhlenschmidt MS; Sibley LD
    Antimicrob Agents Chemother; 2016 Jan; 60(1):570-9. PubMed ID: 26552986
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inactivation and potential repair of Cryptosporidium parvum following low- and medium-pressure ultraviolet irradiation.
    Zimmer JL; Slawson RM; Huck PM
    Water Res; 2003 Aug; 37(14):3517-23. PubMed ID: 12834745
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular cloning and analysis of the Cryptosporidium parvum aminopeptidase N gene.
    Padda RS; Tsai A; Chappell CL; Okhuysen PC
    Int J Parasitol; 2002 Feb; 32(2):187-97. PubMed ID: 11812496
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ultrastructural study of asexual development of Cryptosporidium parvum in a human intestinal cell line.
    Aji T; Flanigan T; Marshall R; Kaetzel C; Aikawa M
    J Protozool; 1991; 38(6):82S-84S. PubMed ID: 1818219
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Complete development of Cryptosporidium parvum in a human endometrial carcinoma cell line.
    Rasmussen KR; Larsen NC; Healey MC
    Infect Immun; 1993 Apr; 61(4):1482-5. PubMed ID: 8454353
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantification of in vitro and in vivo Cryptosporidium parvum infection by using real-time PCR.
    Godiwala NT; Vandewalle A; Ward HD; Leav BA
    Appl Environ Microbiol; 2006 Jun; 72(6):4484-8. PubMed ID: 16751574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enrichment of Cryptosporidium parvum from in vitro culture as measured by total RNA and subsequent sequence analysis.
    Kissinger JC; Hermetz KE; Woods KM; Upton SJ
    Mol Biochem Parasitol; 2018 Mar; 220():5-9. PubMed ID: 29292212
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of 5 types of Cryptosporidium parasites in children in Lima, Peru.
    Xiao L; Bern C; Limor J; Sulaiman I; Roberts J; Checkley W; Cabrera L; Gilman RH; Lal AA
    J Infect Dis; 2001 Feb; 183(3):492-7. PubMed ID: 11133382
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative genomic analysis reveals occurrence of genetic recombination in virulent Cryptosporidium hominis subtypes and telomeric gene duplications in Cryptosporidium parvum.
    Guo Y; Tang K; Rowe LA; Li N; Roellig DM; Knipe K; Frace M; Yang C; Feng Y; Xiao L
    BMC Genomics; 2015 Apr; 16(1):320. PubMed ID: 25903370
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative proteomics reveals Cryptosporidium parvum manipulation of the host cell molecular expression and immune response.
    Li T; Liu H; Jiang N; Wang Y; Wang Y; Zhang J; Shen Y; Cao J
    PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009949. PubMed ID: 34818332
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro development of Cryptosporidium parvum in serum-free media.
    Woods KM; Upton SJ
    Lett Appl Microbiol; 2007 May; 44(5):520-3. PubMed ID: 17451519
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cryptosporidium cell culture infectivity assay design.
    King BJ; Keegan AR; Robinson BS; Monis PT
    Parasitology; 2011 May; 138(6):671-81. PubMed ID: 21414244
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complete development of Cryptosporidium parvum in MDBK cells.
    Villacorta I; de Graaf D; Charlier G; Peeters JE
    FEMS Microbiol Lett; 1996 Aug; 142(1):129-32. PubMed ID: 8759799
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro infection of Cryptosporidium parvum to four different cell lines.
    Yu JR; Choi SD; Kim YW
    Korean J Parasitol; 2000 Jun; 38(2):59-64. PubMed ID: 10905066
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genotyping of Cryptosporidium parvum with microsatellite markers.
    Widmer G; Feng X; Tanriverdi S
    Methods Mol Biol; 2004; 268():177-87. PubMed ID: 15156029
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Application of quantitative real-time reverse transcription-PCR in assessing drug efficacy against the intracellular pathogen Cryptosporidium parvum in vitro.
    Cai X; Woods KM; Upton SJ; Zhu G
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4437-42. PubMed ID: 16251280
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative-PCR assessment of Cryptosporidium parvum cell culture infection.
    Di Giovanni GD; LeChevallier MW
    Appl Environ Microbiol; 2005 Mar; 71(3):1495-500. PubMed ID: 15746352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dynamics of cytokines and immunoglobulins serum profiles in primary and secondary Cryptosporidium parvum infection: usefulness of Luminex® xMAP technology.
    Codices V; Martins C; Novo C; de Sousa B; Lopes Â; Borrego M; Matos O
    Exp Parasitol; 2013 Jan; 133(1):106-13. PubMed ID: 23178641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.